Reckitt Benckiser Group (RBGLD) Price & Analysis

Compare

250 Followers

RBGLD Stock Chart & Stats

$15.72

$0.07(0.58%)

At close: Jan 08 4:00 PM EST

$15.72

$0.07(0.58%)

Day’s Range― - ―

52-Week Range$12.61 - $17.61

Previous CloseN/A

VolumeN/A

Average Volume (3M)20.41K

Market Cap

$55.65B

Enterprise Value$49.72B

Total Cash (Recent Filing)$963.00M

Total Debt (Recent Filing)$9.29B

Price to Earnings (P/E)35.2

Beta0.06

Next Earnings

Mar 05, 2026

EPS Estimate

0.51

Next Dividend Ex-DateN/A

Dividend Yield3.33%

Share Statistics

EPS (TTM)0.40

Shares Outstanding3,223,767,000

10 Day Avg. Volume0

30 Day Avg. Volume20,409

Financial Highlights & Ratios

PEG Ratio-2.25

Price to Book (P/B)5.23

Price to Sales (P/S)2.47

P/FCF Ratio15.80

Enterprise Value/Market Cap0.89

Enterprise Value/Revenue3.56

Enterprise Value/Gross Profit5.84

Enterprise Value/Ebitda17.91

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Brand Portfolio & Multi-channel DistributionA diversified portfolio of global consumer brands and multi-channel distribution provides durable pricing power, customer loyalty and scale advantages. These traits support steady demand, margin resilience and easier product innovation rollout across geographies over the next several quarters.

Robust Cash GenerationStrong operating cash flow and a FCF-to-net-income ratio above 1 indicate sustainable internal funding for capex, R&D, dividends and buybacks. This cash convertibility increases financial resilience, enabling strategic investment and shareholder returns despite cyclical headwinds.

Emerging Markets Growth And Structural Cost SavingsDouble-digit emerging market growth combined with a program that materially reduced fixed costs improves structural revenue diversification and long-term margin potential. These durable shifts reduce reliance on developed markets and sustainably lift adjusted operating profitability.

Bears Say

Recent Revenue ContractionA year-over-year revenue decline signals underlying demand or share challenges that can erode growth unless reversed. Slower top-line trends constrain long-term earnings power and increase reliance on cost cuts or portfolio actions to sustain profit growth over the coming months.

Segment And Regional WeaknessesDeclines in a major region and key product lines are structural risks: loss of momentum in North America and shrinking nutrition/home categories reduce scale and margin diversity. Recovery may require product repositioning, increased marketing or reallocation of resources, taking time to restore growth.

Moderate Leverage And Shrinking Asset BaseModerate leverage and a declining asset base limit financial flexibility for acquisitions or large investments and raise sensitivity to cashflow shocks. Over time this can constrain strategic optionality and increase refinancing or liquidity risk if operating performance softens.

RBGLD FAQ

What was Reckitt Benckiser Group’s price range in the past 12 months?

Reckitt Benckiser Group lowest stock price was $12.61 and its highest was $17.61 in the past 12 months.

What is Reckitt Benckiser Group’s market cap?

Reckitt Benckiser Group’s market cap is $55.65B.

When is Reckitt Benckiser Group’s upcoming earnings report date?

Reckitt Benckiser Group’s upcoming earnings report date is Mar 05, 2026 which is in 8 days.

How were Reckitt Benckiser Group’s earnings last quarter?

Reckitt Benckiser Group released its earnings results on Jul 24, 2025. The company reported $0.397 earnings per share for the quarter, missing the consensus estimate of $0.461 by -$0.064.

Is Reckitt Benckiser Group overvalued?

According to Wall Street analysts Reckitt Benckiser Group’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Reckitt Benckiser Group pay dividends?

Reckitt Benckiser Group pays a Quarterly dividend of $0.227 which represents an annual dividend yield of 3.33%. See more information on Reckitt Benckiser Group dividends here

What is Reckitt Benckiser Group’s EPS estimate?

Reckitt Benckiser Group’s EPS estimate is 0.51.

How many shares outstanding does Reckitt Benckiser Group have?

Reckitt Benckiser Group has 3,223,767,000 shares outstanding.

What happened to Reckitt Benckiser Group’s price movement after its last earnings report?

Reckitt Benckiser Group reported an EPS of $0.397 in its last earnings report, missing expectations of $0.461. Following the earnings report the stock price went up 9.813%.

Which hedge fund is a major shareholder of Reckitt Benckiser Group?

Currently, no hedge funds are holding shares in RBGLD

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Reckitt Benckiser Group Stock Smart Score

Neutral

Fundamentals

Return on Equity

17.21%

Trailing 12-Months

Asset Growth

1.06%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Reckitt Benckiser Group

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products in the United Kingdom, the United States, China, India, and internationally. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands. It also provides analgesics; sore throat medications; and hair removal products under the Nurofen, Strepsils, and Veet brands. In addition, the company offers fragrances and devices; water softeners; home cleaning products; dish washes; toilet cleaners; disinfectants; sprays, baits, and plug-ins for pest control; stain removals; fabric washing; and other hygiene products under the Air Wick, Calgon, Cillit Bang, Finish, Harpic, Lysol, Mortein, Vanish, and Woolite brands, as well as analgesics, adult nutrition products, iron-fortified hypoallergenic baby formula, products for joint issues, and infant and toddler nutrition products, as well as vitamins, minerals, and supplements under the Biofreeze, Airborne, Mead Johnson, Move Free, Enfamil, and Nutramigen brands. Further, it provides probiotics, sore throat pain relief products, Omega products, brain health support products, cleaning and carpet cleaning products, septic tank system treatment products, cough syrups, plant-based laundry products, probiotics, and lubricants under the Digestive Advantage, Cepacol, MegaRed, Neuriva, Easy-Off, RID-X, Delsym, Botanical Origin, Bodi-Ome, and K-Y brands. The company was founded in 1819 and is headquartered in Slough, the United Kingdom.